nafamostat has been researched along with Adenocarcinoma in 3 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
Excerpt | Relevance | Reference |
---|---|---|
" Nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor, inhibited liver metastasis in a CDF1 mice model with colon 26 adenocarcinoma cells." | 3.68 | Inhibitory effect of nafamostat mesilate on metastasis into the livers of mice and on invasion of the extracellular matrix by cancer cells. ( Fuchimoto, S; Hizuta, A; Iwagaki, H; Kimura, T; Orita, K, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Homma, S | 1 |
Hayashi, K | 1 |
Yoshida, K | 1 |
Sagawa, Y | 1 |
Kamata, Y | 1 |
Ito, M | 1 |
Uwagawa, T | 1 |
Li, Z | 1 |
Chang, Z | 1 |
Xia, Q | 1 |
Peng, B | 1 |
Sclabas, GM | 1 |
Ishiyama, S | 1 |
Hung, MC | 1 |
Evans, DB | 1 |
Abbruzzese, JL | 1 |
Chiao, PJ | 1 |
Kimura, T | 1 |
Fuchimoto, S | 1 |
Iwagaki, H | 1 |
Hizuta, A | 1 |
Orita, K | 1 |
3 other studies available for nafamostat and Adenocarcinoma
Article | Year |
---|---|
Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
Topics: Adenocarcinoma; B7-H1 Antigen; Benzamidines; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, | 2018 |
Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Benzamidines; Caspase 8; Cell Line, Tumor; Enzyme | 2007 |
Inhibitory effect of nafamostat mesilate on metastasis into the livers of mice and on invasion of the extracellular matrix by cancer cells.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antithrombins; Benzamidines; Colonic Neoplasms; Extr | 1992 |